Filing Details

Accession Number:
0001493152-24-014509
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-15 06:02:28
Reporting Period:
2024-04-11
Accepted Time:
2024-04-15 06:02:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472122 Andrew Arno C/O Oncocyte Corporation
15 Cushing
Irvine CA 92618
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2024-04-11 33,898 $2.95 69,054 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, No Par Value 7,804 Indirect See footnote
Common Stock, No Par Value 7,804 Indirect See footnote
Footnotes
  1. Reflects shares of the Issuer's common stock, no par value ("Common Stock"), purchased by the Reporting Person from the Issuer in a private offering.
  2. These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here.
  3. These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.